This randomized controlled clinical trial will assess whether continuation of home oral
antidiabetic agents during hospitalization can be used as a safe and effective alternative to
insulin therapy in the management of diabetes in the hospital. The primary outcome of the
study is to determine differences in glycemic control as measured by mean daily blood glucose
concentration between oral antidiabetic medications and basal bolus therapy in hospitalized
patients with type 2 diabetes (T2D).
Phase:
Phase 4
Details
Lead Sponsor:
Emory University
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)